Información del producto
- (1α,3α,6α,14α,16β)-20-Ethyl-1,6,16-trimethoxy-4-(methoxymethyl)-8-acetate 14-(4-methoxybenzoate)aconitane-3,8,13,14-tetrol
- Isoaconitine (6CI)
- Vilmorrianine B (7CI)
- 11aH-12,3,6a-Ethanylylidene-7,9-methanonaphth[2,3-b]azocine, Aconitane-3,8,13,14-tetrol Deriv.
- 3α,13-Dihydroxyforesaconitine
- Guayewuanine B
- Yunaconitine
- (1alpha,3alpha,6alpha,14alpha,16beta)-8-Acetoxy-20-ethyl-3,13-dihydroxy-1,6,16-trimethoxy-4-(methoxymethyl)aconitan-14-yl 4-methoxybenzoate
- 11aH-12,3,6a-Ethanylylidene-7,9-methanonaphth[2,3-b]azocine, aconitane-3,8,13,14-tetrol deriv.
- 8-(Acetyloxy)-20-Ethyl-3,13-Dihydroxy-1,6,16-Trimethoxy-4-(Methoxymethyl)Aconitan-14-Yl 4-Methoxybenzoate
- Ver más sinónimos
- Aconitane-3,8,13,14-tetrol, 20-ethyl-1,6,16-trimethoxy-4-(methoxymethyl)-, 8-acetate 14-(4-methoxybenzoate), (1α,3α,6α,14α,16β)-
- Isoaconitine
- Vilmorrianine B
Applications Yunnaconitine is a metabolite of Aconitine (A189875), a neurotoxin that binds, activates tetrodotoxin-sensitive Na+ channels and prolongs the opening of the sodium-ion channel by suppressing conformational changes. Yunnaconitine is a deiterpene alkaloid, known to exhibit cytotoxic activity in human leukemic cell.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References He, Y.Q., et al.: J. Pharma. Analysis., 1, 57 (2011); Derbre, S., et al.: Anal. Bioanal. Chem., 398, 1747 (2010); Li, M., et al.: J. Pharm. Biomed. Anal., 53, 1063 (2010);
Propiedades químicas
Consulta técnica sobre: TR-Y100900 Yunnaconitine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.